![]() ![]() ![]() However, until recently, some of the syrups were still being sold in private clinics and in hospitals, he said. He said the number of deaths has tapered off in recent weeks and that the sale of products made by Maiden Pharmaceuticals was banned. Our involvement in student life is essential in making college life a valuable experience. At The Gambia College we encourage students to participate in outside of classroom activities, and learn from those experiences. Gambia's director of health services, Mustapha Bittaye, said similar problems have been detected in other syrups but that the ministry is awaiting confirmation of the results. The Gambia College A thriving community of divers people from across the Gambia and the world. The deaths confounded medics before a pattern emerged: dozens of patients younger than five were falling ill three to five days after taking a locally sold paracetamol syrup. Medical officers in Gambia raised the alarm in July, after dozens of children began falling ill with kidney problems. Lab analysis confirmed "unacceptable" amounts of diethylene glycol and ethylene glycol, which can be toxic and lead to acute kidney injury, the WHO said. The Gambias health ministry asked hospitals last month to stop using a syrup paracetamol, pending the outcome of an investigation, after at least 28 children died of kidney failure. The alert covers four products: Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup. The products may have been distributed elsewhere through informal markets, but had so far been identified only in Gambia, the WHO said in its alert. The WHO issued a medical product alert on Wednesday asking regulators to remove Maiden Pharma goods from the market. India's health ministry did not respond to a request for comment. Maiden Pharma declined to comment, while calls and messages to the Drugs Controller General of India went unanswered. agency was conducting an investigation with Indian regulators and the company that made the syrups, New Delhi-based Maiden Pharmaceuticals Ltd. The findings, announced by WHO Director-General Tedros Adhanom Ghebreyesus, followed tests on several medicinal syrups that were suspected of causing 66 child deaths in the tiny West African country. WHO said that information received from India's Central Drugs Standard Control Organisation indicated that the manufacturer had only supplied the contaminated medications to The Gambia.The deaths of dozens of young children in Gambia from acute kidney injuries may be linked to contaminated cough and cold syrups made by an Indian drug manufacturer, the World Health Organization said on Wednesday. The Gambia's health ministry asked hospitals last month to stop using a syrup paracetamol, pending the outcome of an investigation, after at least 28 children died of kidney failure. Those substances are toxic to humans and can be fatal, it said, adding that the toxic effect "can include abdominal pain, vomiting, diarrhoea, inability to pass urine, headache, altered mental state and acute kidney injury which may lead to death." "To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products," the alert said, adding that laboratory analysis of samples of the products "confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants." The online portal thanked the incumbent president for taking The Gambia to the Africa Cup of Nations in Cameroon. ![]() Tedros said that WHO was also "conducting further investigation with the company and regulatory authorities in India."Īccording to the medical product alert issued by WHO Wednesday, the four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup. One of the foreign-based popular Gambian affairs online portal, What’s On Gambia has shown their support to the incumbent GFF president Lamin Kaba Bajo ahead of the August 27 national football elections. WHO is conducting further investigation with the company and regulatory authorities in India"- World Health Organization (WHO) October 5, 2022 "The four medicines are cough and cold syrups produced by Maiden Pharmaceuticals Limited, in India. "The loss of these young lives is beyond heartbreaking for their families." ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |